Advagene Biopharma Market Cap

Advagene Biopharma has a market cap or net worth of 1.83 billion as of March 9, 2026. Its market cap has increased by 50.49% in one year.

Market Cap

1.83B

Enterprise Value

1.67B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

29.95

Market Cap Chart

Since November 29, 2018, Advagene Biopharma's market cap has increased from 1.16B to 1.83B, an increase of 58.09%. That is a compound annual growth rate of 6.49%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	1.83B	9.98%
Dec 31, 2025	1.67B	36.50%
Dec 31, 2024	1.22B	-9.95%
Dec 29, 2023	1.36B	-8.36%
Dec 30, 2022	1.48B	-38.27%
Dec 30, 2021	2.40B	63.31%
Dec 31, 2020	Pro	Pro
Dec 25, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anti-Microbial Savior BioteQ	1.84B
Genomics BioSci & Tech.	1.75B
TaiRx	1.97B
Chunghwa Chemical Synthesis & Biotech	2.07B
GenMont Biotech Incorporation	1.54B
G&E Herbal Biotechnology	2.19B
NeoCore Technology	1.50B
Gwo Xi Stem Cell Applied Technology Co. ,	2.26B

Market Cap Rankings